[Chemotherapy for peritoneal dissemination in gastric cancer under ureteral catheterization].

Abstract

The treatment of peritoneal dissemination of gastric cancer is mainly chemotherapy, but it use is often limited by ileus, hydronephrosis and jaundice. We employed a ureteral catheter for 6 patients with hydronephrosis due to peritoneal dissemination. Chemotherapy (CDDP + ADM + 5-FU or MTX + 5-FU) was administered in 5 patients. After ureteral catheterization, renal function was kept within normal ranges, so chemotherapy was performed safely. One of five patients became CR and the effect of the treatment was satisfactory (PR: 1, NC: 2). Thus, chemotherapy after ureteral catheterization may be effective for patients with peritoneal dissemination and hydronephrosis.

• Authors: Y Kubo, A Kurita, T Saeki, N Yokoyama, M Tanada, W Takiyama, H Saeki, S Takashima
• Journal: Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 23 Issue 14 Pg. 1951-7 (Dec 1996) ISSN: 0385-0684 [Print] Japan
• PMID: 8978803 (Publication Type: Case Reports, Clinical Trial, English Abstract, Journal Article)

Chemical References

• Doxorubicin
• Cisplatin
• Fluorouracil

Topics

• Adenocarcinoma (drug therapy, secondary)
• Aged
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Cisplatin (administration & dosage)
• Doxorubicin (administration & dosage)
• Female
• Fluorouracil (administration & dosage)
• Humans
• Hydronephrosis (complications, therapy)
• Male
• Middle Aged
• Peritoneal Neoplasms (drug therapy, secondary)
• Stomach Neoplasms (drug therapy, pathology)
• Urinary Catheterization